Teva, Allergan settle Rhode Island opioid suit for $107M: 3 notes

Allergan and Teva Pharmaceuticals have settled allegations that they helped fuel Rhode Island’s opioid epidemic, state Attorney General Peter Neronha said March 21.

Advertisement

Three notes:

1. As part of the settlement, the drugmakers will pay the state a combined $28.5 million in cash over the next 13 years.

2. They’ll also give Rhode Island 1 million doses of naloxone, which can be used to reverse the effects of an opioid overdose, and 67,000 30-pill bottles of Suboxone, a medication used to treat opioid use disorder, in various doses for free over the next 10 years.

3. The deal results in a combined settlement value of $107 million. 

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Advertisement

Next Up in Legal & Regulatory Issues

Advertisement

Comments are closed.